CVRx Inc
General ticker "CVRX" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $316.6M
CVRx Inc does not follow the US Stock Market performance with the rate: -22.2%.
Estimated limits based on current volatility of 3.4%: low 11.95$, high 12.79$
Factors to consider:
- US accounted for 89.4% of revenue in the fiscal year ended 2023-12-31
- Current price 12.7% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [14.78$, 31.75$]
- 2024-12-30 to 2025-12-30 estimated range: [10.58$, 24.42$]
Financial Metrics affecting the CVRX estimates:
- Negative: Non-GAAP EPS, $ of -1.98 <= 0.10
- Negative: Operating profit margin, % of -52.31 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -7.43 <= 2.35
- Positive: Industry inventory ratio change (median), % of 0.19 <= 0.49
Short-term CVRX quotes
Long-term CVRX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $13.04MM | $22.47MM | $39.30MM |
| Operating Expenses | $39.00MM | $65.00MM | $82.40MM |
| Operating Income | $-25.97MM | $-42.53MM | $-43.10MM |
| Non-Operating Income | $-17.02MM | $1.21MM | $2.05MM |
| Interest Expense | $2.22MM | $0.17MM | $1.80MM |
| R&D Expense | $7.50MM | $9.95MM | $11.63MM |
| Income(Loss) | $-42.99MM | $-41.32MM | $-41.05MM |
| Taxes | $0.09MM | $0.11MM | $0.15MM |
| Profit(Loss) | $-43.08MM | $-41.43MM | $-41.20MM |
| Stockholders Equity | $145.96MM | $109.18MM | $75.95MM |
| Inventory | $3.88MM | $6.96MM | $10.98MM |
| Assets | $152.55MM | $124.94MM | $115.23MM |
| Operating Cash Flow | $-27.73MM | $-42.68MM | $-39.02MM |
| Capital expenditure | $1.18MM | $0.69MM | $0.59MM |
| Investing Cash Flow | $-1.18MM | $-0.69MM | $-0.59MM |
| Financing Cash Flow | $111.88MM | $7.49MM | $23.98MM |
| Earnings Per Share* | $-2.11 | $-2.02 | $-1.99 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.